Effect of Probiotics After Neurosurgery
The Multistrain Probiotic OMNi-BiOTiC® Hetox for Treatment After Neurosurgery (ProSURG)
University Maribor
110 participants
Nov 3, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC® Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery. The main question it aims to answer is: • Is the multistrain probiotic OMNi-BiOTiC® Hetox effective in in improving patient-reported disability after neurosurgery? Researchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.
Eligibility
Inclusion Criteria4
- adults with MRI-confirmed disc herniation, stenosis, or instability of the lumbar or cervical spine.
- Able to provide written informed consent
- Willing to comply with study procedures and follow-up assessments
- No contraindications to probiotic administration
Exclusion Criteria3
- symptoms of acute infection (vomiting, fever above 38°C, diarrhea, respiratory symptoms),
- chronic diseases,
- use of probiotics one month before inclusion.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OMNi-BiOTiC® Hetox multistrain probiotic
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07200518